Dysregulation of proBDNF/p75NTR and BDNF/TrkB Signaling in Acute Ischemic Stroke: Different Sides of the Same Coins DOI Creative Commons

Hala Alnoaman,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Brain Research Bulletin, Journal Year: 2025, Volume and Issue: unknown, P. 111338 - 111338

Published: April 1, 2025

Acute ischemic stroke (AIS) is a focal neurological deficit due to sudden occlusion of cerebral vessels in the brain. AIS-induced neuronal injury and associated excite-toxicity neurodegeneration affect synthesis release different neurotrophic factors such as brain-derived neurotropic factor (BDNF) its precursor proBDNF. Both BDNF proBDNF act on specific receptors with effects. activates tropomyosin receptor kinase B (TrkB) results promoting survival, synaptic plasticity, growth. However, p75 neurotrophin (p75NTR) sortilin which attenuates plasticity promotes apoptosis. Dysregulation central peripheral expression proBDNF/BDNF linked severity clinical outcomes AIS. Therefore, this review aims discuss alterations signaling Findings from present illustrated that proBDNF/p75NTR/sortilin pathway exaggerated whereas; BDNF-TrkB reduced AIS leading activation signaling, inhibition could be promising therapeutic strategy management

Language: Английский

Pathophysiology of Post-COVID syndromes: a new perspective DOI Creative Commons
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Virology Journal, Journal Year: 2022, Volume and Issue: 19(1)

Published: Oct. 9, 2022

Most COVID-19 patients recovered with low mortality; however, some experienced long-term symptoms described as "long-COVID" or "Post-COVID syndrome" (PCS). Patients may have persisting for weeks after acute SARS-CoV-2 infection, including dyspnea, fatigue, myalgia, insomnia, cognitive and olfactory disorders. These last months in patients. PCS progress association the development of mast cell activation syndrome (MCAS), which is a distinct kind disorder, characterized by hyper-activation cells inappropriate excessive release chemical mediators. survivors, mainly women, persistent severe fatigue 10 recovery history neuropsychiatric disorders are more prone to develop PCS. High D-dimer levels blood urea nitrogen were observed be risk factors associated pulmonary dysfunction survivors 3 post-hospital discharge has systemic manifestations that resolve time no further complications. However, final outcomes chiefly unknown. Persistence inflammatory reactions, autoimmune mimicry, reactivation pathogens together host microbiome alterations contribute The deregulated mediators MCAS produces extraordinary during course infection correlated severity Therefore, treated antihistamines, inhibition synthesis mediators, mediator release, degranulation cells.

Language: Английский

Citations

99

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle DOI
Hayder M. Al‐kuraishy, Majid S. Jabir,

Ali K. Albuhadily

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 95, P. 102233 - 102233

Published: Feb. 14, 2024

Language: Английский

Citations

20

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy DOI
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 95, P. 102209 - 102209

Published: Jan. 28, 2024

Language: Английский

Citations

17

A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease DOI
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh

et al.

Neurochemical Research, Journal Year: 2022, Volume and Issue: 48(3), P. 745 - 766

Published: Nov. 21, 2022

Language: Английский

Citations

59

Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review DOI Creative Commons

Nawal Alsubaie,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Brain Sciences, Journal Year: 2022, Volume and Issue: 12(10), P. 1290 - 1290

Published: Sept. 24, 2022

Alzheimer's disease (AD) was used to describe pre-senile dementia differentiate it from senile dementia, which develops in the adult age group of more than 65 years. AD is characterized by deposition amyloid beta (Aβ) plaque and tau-neurofibrillary tangles (TNTs) brain. The neuropathological changes are related plaques, neurofibrillary tangles, progression neuroinflammation, neuronal mitochondrial dysfunction, autophagy cholinergic synaptic dysfunction. Statins one main cornerstone drugs for management cardiovascular disorders regardless dyslipidemia status. Increasing use statins, mainly elderly groups primary secondary prevention diseases, may affect their cognitive functions. Extensive prolonged statins functions healthy subjects patients. Statins-induced impairments both patients health providers had been reported according post-marketing survey. This survey depends on sporadic cases, no measures were used. Evidence prospective observational studies gives robust conclusion regarding beneficial or detrimental effects Therefore, this study a narrative review aimed with evidences beneficial, detrimental, neutral AD.

Language: Английский

Citations

54

Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure DOI Creative Commons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου

et al.

Journal of Diabetes, Journal Year: 2022, Volume and Issue: 14(12), P. 806 - 814

Published: Nov. 28, 2022

Type 2 diabetes mellitus (T2DM) is a chronic endocrine disorder due to the reduction of insulin sensitivity and relative deficiency secretion. Growth differentiation factor 15 (GDF15) belongs transforming growth beta (TGF-β) superfamily was initially identified as macrophage inhibitory cytokine-1 (MIC-1). GDF15 considered cytokine with an anti-inflammatory effect increases sensitivity, reduces body weight, improves clinical outcomes in diabetic patients. acts through stimulation glial-derived neurotrophic (GDNF) family receptor α-like (GFRAL), which highly expressed brain stem induce taste aversion. Metformin group biguanides that are derived from plant Galega officinalis. It interesting note metformin insulin-sensitizing agent used first-line therapy for T2DM has been shown increase circulating level GDF15. Thus, present review aims determine critical association biomarker how agents affect it. This illustrates activates expression, appetite leads weight loss both nondiabetic However, cannot give conclusion this regard. Therefore, experimental, preclinical, studies warranted confirm potential role patients.2型糖尿病(T2DM)是一种因胰岛素敏感性降低和胰岛素分泌相对不足而引起的慢性内分泌疾病。生长分化因子15 (GDF15)属于转化生长因子-β (TGF-β)超家族,最初被鉴定为巨噬细胞抑制因子-1 (MIC)。GDF15被认为是一种具有抗炎作用、增加胰岛素敏感性、减轻体重和改善糖尿病患者临床疗效的细胞因子。GDF15通过刺激脑干高表达的胶质源性神经营养因子(GDNF)家族受体α样(GFRAL)诱导味觉厌恶。二甲双胍属于从大戟属植物中提取的双胍类化合物。二甲双胍是一种胰岛素增敏剂,用于T2DM的一线治疗,已被证明可增加GDF15的循环水平。本综述旨在确定GDF15生物标志物在T2DM中的关键作用以及二甲双胍药物是如何影响它发。综述表明,二甲双胍激活GDF15的表达,降低糖尿病和非糖尿病患者的食欲,诱导体重减轻。然而,目前的研究无法在这方面给出结论。因此,有必要进行实验、临床前和临床研究来确认GDF15在T2DM患者中的潜在作用。.

Language: Английский

Citations

41

Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link DOI Creative Commons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaser Hosny Ali Elewa

et al.

Cellular and Molecular Neurobiology, Journal Year: 2023, Volume and Issue: 43(6), P. 2743 - 2759

Published: April 19, 2023

Abstract Parkinson’s disease (PD) is one of the most common degenerative brain disorders caused by loss dopaminergic neurons in substantia nigra (SN). Lewy bodies and -synuclein accumulation SN are hallmarks neuropathology PD. Due to lifestyle changes prolonged L-dopa administration, patients with PD frequently have vitamin deficiencies, especially folate, B6, B12. These augment circulating levels Homocysteine development hyperhomocysteinemia, which may contribute pathogenesis Therefore, this review aimed ascertain if hyperhomocysteinemia play a part oxidative inflammatory signaling pathways that development. Hyperhomocysteinemia implicated neurodegenerative disorders, including triggers progression different mechanisms, stress, mitochondrial dysfunction, apoptosis, endothelial dysfunction. Particularly, linked high systemic disorders. induces immune activation stress. In turn, activated response promotes hyperhomocysteinemia. hyperhomocysteinemia-induced immunoinflammatory abnormal aggravate PD, leading more severity. Also, like nuclear factor kappa B (NF-κB) nod-like receptor pyrin 3 (NLRP3) inflammasome other intricate conclusion, involved either directly via induction degeneration or indirectly pathways.

Language: Английский

Citations

39

Depression and type 2 diabetes: A causal relationship and mechanistic pathway DOI Creative Commons
Wael Y. Khawagi, Hayder M. Al‐kuraishy,

Nawar R. Hussein

et al.

Diabetes Obesity and Metabolism, Journal Year: 2024, Volume and Issue: 26(8), P. 3031 - 3044

Published: May 27, 2024

Abstract Depression is a mood disorder that may increase risk for the development of insulin resistance (IR) and type 2 diabetes (T2D), vice versa. However, mechanistic pathway linking depression T2D not fully elucidated. The aim this narrative review, therefore, was to discuss possible link between T2D. coexistence twice as great compared occurrence either condition independently. Hyperglycaemia dyslipidaemia promote incidence by enhancing inflammation reducing brain serotonin (5‐hydroxytryptamine [5HT]). Dysregulation signalling in impairs 5HT signalling, leading depression. Furthermore, associated with hyperglycaemia poor glycaemic control. Psychological stress In conclusion, could be potential factor through induction inflammatory reactions oxidative affect neurotransmission. addition, chronic induce dysregulation hypothalamic–pituitary–adrenal axis circulating cortisol levels, which triggers IR

Language: Английский

Citations

16

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon DOI
Hayder M. Al‐kuraishy,

Sadiq M. Al‐Hamash,

Majid S. Jabir

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 94, P. 102200 - 102200

Published: Jan. 17, 2024

Language: Английский

Citations

10

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal DOI Creative Commons
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Inflammopharmacology, Journal Year: 2022, Volume and Issue: 31(1), P. 1 - 7

Published: Nov. 23, 2022

Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due to neuronal tropism of severe acute respiratory syndrome type 2 (SARS-CoV-2) and/or associated immune activation, cytokine storm, and psychological stress. SARS-CoV-2 infection linked storm cause blood–brain barrier (BBB) injury through which activated cells can pass into the brain causing activation glial with subsequent neuroinflammation. Different therapeutic regimens were suggested alleviate Covid-19-induced Since glibenclamide has anti-inflammatory neuroprotective effects, it could be effective in mitigation infection-induced Glibenclamide is a second-generation drug from sulfonylurea family, acts by inhibiting adenosine triphosphate (ATP)-sensitive K channel regulatory subunit 1 receptor (SUR-1) pancreatic β cells. reduces BBB nod-like pyrin 3 (NLRP3) inflammasome, oxidative stress, microglial activation. Therefore, inhibition NLRP3 stress attenuate SARS-CoV-2-mediated

Language: Английский

Citations

37